Indications include
- Various solid tumors/basket trials
- Breast cancer
- Prostate cancer
- Lung cancer: Non-Small-Cell Lung Carcinoma (NSCLC ) and Small-Cell Lung Carcinoma (SLC)
- Kidney cancer
- Bladder/urinary tract cancer
- Melanoma
- Basal Cell Carcinoma, BCCNS (Gorlin)
- Oesophageal and Gastric cancers
- Liver cancer/Hepatoblastoma
- Cholangiocarcinoma
- Gastrointestinal stromal tumors (GISTs)
- Thyroid cancer
- Head and Neck cancers
- Glioblastoma and other CNS cancers
- Neuroblastoma
- Neuroendocrine tumors
- Carcinoid tumors/Carcinoid syndrome
- Pancreas cancer
- Soft tissue Sarcoma/Epithelioid Sarcoma
Recent assignments
- Prepare and submit EU ODD Annual Report for a drug to treat bone and tissue cancer
- Prepare gap analysis of the post-approval change management protocol
- Develop the safety and risk portfolio for an IVD/CDx
- Develop & submit EU CTA for a phase 2b study with a GMO product
- Provide pre-market PV Services in Europe for a drug against pancreatic cancer
- Assistance in early dialogue with HTA bodies
Products
Projects